Jennifer A Shabbits1, Yanping Hu, Lawrence D Mayer. 1. Department of Advanced Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada. jshabbit@bccancer.bc.ca
Authors: Alejandro Bravo-Cuellar; Pablo C Ortiz-Lazareno; Jose M Lerma-Diaz; Jorge R Dominguez-Rodriguez; Luis F Jave-Suarez; Adriana Aguilar-Lemarroy; Susana del Toro-Arreola; Ruth de Celis-Carrillo; Jose E Sahagun-Flores; Javier E Garcia de Alba-Garcia; Georgina Hernandez-Flores Journal: Mol Cancer Date: 2010-05-19 Impact factor: 27.401
Authors: Sven Rottenberg; Anders O H Nygren; Marina Pajic; Fijs W B van Leeuwen; Ingrid van der Heijden; Koen van de Wetering; Xiaoling Liu; Karin E de Visser; Kenneth G Gilhuijs; Olaf van Tellingen; Jan P Schouten; Jos Jonkers; Piet Borst Journal: Proc Natl Acad Sci U S A Date: 2007-07-11 Impact factor: 11.205
Authors: Daniela Carlisi; Anna De Blasio; Rosa Drago-Ferrante; Riccardo Di Fiore; Giuseppina Buttitta; Marco Morreale; Christian Scerri; Renza Vento; Giovanni Tesoriere Journal: Cell Death Discov Date: 2017-12-04